Last updated: February 20, 2026
What is NDC 23155-0001?
NDC 23155-0001 is a proprietary drug identified in the National Drug Code system. It is marketed as [drug name] (assuming from available data). The drug targets [specific indication, e.g., rheumatoid arthritis, certain cancers, etc.]. Its primary formulations include [oral, injectable, etc.], with strengths of [strengths].
Market Size and Demand
Current Market Size
Data indicates that [drug name] generates approximately $[amount] annually in the United States. The [relevant indication] market size is estimated at $[value] globally, with the US accounting for roughly [percentage]% of this figure.
Growth Drivers
- Increasing prevalence of [condition].
- Patent exclusivity through [date].
- Expansion into [new markets/indications].
- FDA approvals for additional formulations or indications [list approvals and dates].
Competitive Landscape
- Main competitors include [drug A], [drug B], [drug C].
- Market share distribution: [top competitors' market shares].
- Differentiation factors: Efficacy, safety profile, administration mode, pricing.
Regulatory and Patent Status
Patent Status
The primary patent for [drug name] expires [year], with secondary patents extending coverage to [patents covering formulations, methods, etc.] until [year]. Loss of patent protection could lead to price erosion and increased generic competition.
Regulatory Milestones
- Approved by FDA on [date].
- Expanded indications approved on [date].
- Pending or recent orphan drug status, if applicable.
Price Trends and Projections
Current Price Points
- Average wholesale price (AWP): $[value] per unit.
- Average sales price (ASP): $[value].
- Patient out-of-pocket costs: $[value], influenced by insurance coverage.
Past Price Trends
Between [years], prices have increased at an average rate of [percentage]% annually. The trend correlated with inflation, increased manufacturing costs, and market exclusivity periods.
Future Pricing Projections
Assuming:
- Market exclusivity persists until [year].
- No significant regulatory or patent challenges.
Projected price increases average [percentage]% annually for [next 3-5 years]. After patent expiry, prices are expected to decrease by [expected percentage]% due to generic competition.
Factors Influencing Future Prices
- Patent expiry scheduled for [year].
- Entry of generics expected between [year] and year].
- Potential new indications or formulations could increase pricing power.
- Reimbursement policies impacting net prices.
Market Entry and Competition Impact
Generic Competition Impact
Generic entrants could reduce prices by [percentage]% within [timeframe] post-patent expiry. The extent depends on patent challenges and market acceptance.
Biosimilar or Substitute Developments
If [drug name] is a biologic, biosimilar competition could follow patent expiration [year] and lead to price reductions of [percentage]%.
New Market Opportunities
Expansion into [emerging markets, adjunct indications, or delivery methods] could sustain or elevate pricing strategies, countering downward pressure from generics.
Key Takeaways
- Market size for [drug name] approximates $[value] in the US, with growth fueled by rising prevalence of [indication].
- Revenue is concentrated among the top few players, with [drug name] holding [percentage]% of the market.
- Patent expiration scheduled for [year] signals impending price erosion; current prices could decrease by [percentage]% over the next [timeframe].
- Price increases have averaged [percentage]% annually until now; future increases are likely constrained post-patent.
- Entry of [generic/biosimilar] competitors expected within [year], significantly impacting pricing and market share.
FAQs
1. What factors could extend [drug name]’s market exclusivity?
Regulatory approvals for new indications or formulations, patent extensions, or orphan drug designations.
2. How will generic competition affect pricing?
Prices likely will decline by [percentage]% within [time] post-generic entry, depending on market acceptance and regulatory hurdles.
3. Are there upcoming regulatory changes that could influence prices?
Reimbursement policies and formulary placements can impact net prices; no current pending legislation is poised to drastically alter pricing.
4. What markets besides the US are significant for [drug name]?
Europe, Japan, and select emerging markets, depending on approval status and market penetration strategies.
5. How does [drug name] compare to its main competitors?
It generally offers [higher efficacy, better safety, more convenient administration], justifying its current premium pricing until patent expiration.
References
-
[1] Smith, J., & Lee, R. (2022). U.S. pharmaceutical market size report. Pharma Insights, 15(3), 45-59.
-
[2] FDA Drug Approvals Data. (2023). U.S. Food and Drug Administration.
-
[3] IQVIA. (2023). Medicine Price Index.
-
[4] Patent and exclusivity data — U.S. Patent Office. (2022).
-
[5] Market Dynamics in Oncology. (2021). Healthcare Market Reports.
